Lee Nam-Hun, Son Chang-Gue
Liver and Immunology Research Center, Daejeon Oriental Hospital of Daejeon University, Korea.
J Acupunct Meridian Stud. 2011 Jun;4(2):85-97. doi: 10.1016/S2005-2901(11)60013-7.
This systematic review aims to evaluate the available evidence from randomized clinical trials of the clinical efficacy and safety of ginseng. Systematic literature searches were performed in 13 databases up to March 2009 without language restriction. All randomized clinical trials evaluating the clinical effects or safety of the use of ginseng monopreparations (Panax ginseng or P. quinquefolium) were considered for inclusion. A total of 411 potentially relevant studies were identified and 57 randomized clinical trials were included. The main indications included glucose metabolism, physical performance, psychomotor function, sexual function, cardiac function, pulmonary disease, and cerebrovascular disease. We found strong evidence of a positive effect of ginseng on glucose metabolism, psychomotor function, and pulmonary disease, whereas evidence suggests that ginseng is not effective at enhancing physical performance. However, ginseng generally has a good safety profile and the incidence of adverse effects seems to be low. In conclusion, our review compiles the evidence on the use of ginseng, finding a strong positive potential for glucose metabolism, psychomotor function, and pulmonary disease, but not for physical performance enhancement.
本系统评价旨在评估人参临床疗效与安全性的随机临床试验的现有证据。截至2009年3月,在13个数据库中进行了无语言限制的系统文献检索。所有评估人参单一制剂(人参或西洋参)使用的临床效果或安全性的随机临床试验均被纳入考虑。共识别出411项潜在相关研究,纳入了57项随机临床试验。主要适应证包括糖代谢、身体机能、精神运动功能、性功能、心功能、肺部疾病和脑血管疾病。我们发现有力证据表明人参对糖代谢、精神运动功能和肺部疾病有积极作用,而证据表明人参在增强身体机能方面无效。然而,人参总体安全性良好,不良反应发生率似乎较低。总之,我们的综述汇总了人参使用的证据,发现其对糖代谢、精神运动功能和肺部疾病有强大的积极潜力,但对增强身体机能无此作用。